SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-096564
Filing Date
2011-11-08
Accepted
2011-11-08 17:12:56
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y92563e10vq.htm 10-Q 683201
2 EX-31.1 y92563exv31w1.htm EX-31.1 7355
3 EX-31.2 y92563exv31w2.htm EX-31.2 7369
4 EX-32.1 y92563exv32w1.htm EX-32.1 2198
5 EX-32.2 y92563exv32w2.htm EX-32.2 2212
  Complete submission text file 0000950123-11-096564.txt   8186357

Data Files

Seq Description Document Type Size
7 EX-101 INSTANCE DOCUMENT mrk-20110930.xml EX-101.INS 1669262
8 EX-101 SCHEMA DOCUMENT mrk-20110930.xsd EX-101.SCH 70805
9 EX-101 CALCULATION LINKBASE DOCUMENT mrk-20110930_cal.xml EX-101.CAL 72668
10 EX-101 LABELS LINKBASE DOCUMENT mrk-20110930_lab.xml EX-101.LAB 542318
11 EX-101 PRESENTATION LINKBASE DOCUMENT mrk-20110930_pre.xml EX-101.PRE 392635
12 EX-101 DEFINITION LINKBASE DOCUMENT mrk-20110930_def.xml EX-101.DEF 262461
Mailing Address ONE MERCK DRIVE P.O. BOX 100 WHITEHOUSE STATION NJ 08889-0100
Business Address ONE MERCK DRIVE P.O. BOX 100 WHITEHOUSE STATION NJ 08889-0100 908-423-4840
Merck & Co. Inc. (Filer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06571 | Film No.: 111188685
SIC: 2834 Pharmaceutical Preparations